Molecular Epidemiology and Clone Transmission of Carbapenem-Resistant Acinetobacter baumannii in ICU Rooms

Molecular Epidemiology and Clone Transmission of Carbapenem-Resistant Acinetobacter baumannii in ICU Rooms

Carbapenem-resistant Acinetobacter baumannii (CRAB) is a major cause of nosocomial infections and hospital outbreaks worldwide, remaining a critical clinical concern. Here we characterized and investigated the phylogenetic relationships of 105 CRAB isolates from an intensive care unit from one hospi...

Full description

Bibliographic Details
Main Authors:	Xiufeng Zhang, Fangping Li, Furqan Awan, Hongye Jiang, Zhenling Zeng, Weibiao Lv
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2021-02-01
Series:	Frontiers in Cellular and Infection Microbiology
Subjects:	carbapenem-resistant Acinetobacter baumannii whole-genome sequencing clone spread nosocomial infection
Online Access:	https://www.frontiersin.org/articles/10.3389/fcimb.2021.633817/full

Similar Items

Preoptimized phage cocktail for use in aerosols against nosocomial transmission of carbapenem-resistant Acinetobacter baumannii: A 3-year prospective intervention study
by: Li-Kuang Chen, et al.
Published: (2022-05-01)

A global view on carbapenem-resistant Acinetobacter baumannii
by: Carina Müller, et al.
Published: (2023-12-01)

Evaluación microbiológica y epidemiológica de los clones de Acinetobacter baumannii resistentes a los carbapenemes aislados en la unidad de cuidados intensivos de un Hospital Universitario de la ciudad de Buenos Aires Microbiological and epidemiological evaluation of carbapenem-resistant Acinetobacter baumannii clones isolated at an intensive care unit of a University Hospital in Buenos Aires city
by: C. H. Rodriguez, et al.
Published: (2009-09-01)

Nosocomial carbapenem-drug resistant Acinetobacter baumannii, related factors and clinical outcomes in Northeast Iran
by: Yasaman Alidoosti, et al.
Published: (2024-10-01)

Occurrence of Acinetobacter baumannii genomic resistance islands (AbGRIs) in Acinetobacter baumannii strains belonging to global clone 2 obtained from COVID-19 patients
by: Ghazal Naderi, et al.
Published: (2023-08-01)

Prevalence of infections with antibiotic-resistant Acinetobacter baumannii in different clinical samples from hospitals in Erbil
by: Sakar B. Smai, et al.
Published: (2020-06-01)

A Prevalence of infections with antibiotic-resistant Acinetobacter baumannii in different clinical samples from hospitals in Erbil
by: Sakar B. Smai, et al.
Published: (2020-06-01)

Indications of carbapenem resistance evolution through heteroresistance as an intermediate stage in Acinetobacter baumannii after carbapenem administration Indicações da evolução da resistência ao carbapenem através da heteroresistência como estágio intermediário no Acinetobacter baumannii após administração de carbapenem
by: Silvana Vargas Superti, et al.
Published: (2009-04-01)

Dissemination of multiple carbapenem-resistant clones of Acinetobacter baumannii in the Eastern District of Saudi Arabia
by: Abdulrahman eAl-Sultan, et al.
Published: (2015-07-01)

In vitro activity of tigecycline against clinical isolates of carbapenem resistant <it>Acinetobacter baumannii</it> complex in Pretoria, South Africa
by: Ahmed Nahid H, et al.
Published: (2012-05-01)

Detection of Clonal Relationship Between Carbapenem-resistant Acinetobacter baumannii Isolates in an University Hospital
by: Yasemin KIRIK, et al.
Published: (2021-12-01)

The influence of carbapenem resistance on mortality in solid organ transplant recipients with <it>Acinetobacter baumannii</it> infection
by: de Gouvêa Erika, et al.
Published: (2012-12-01)

The impact and risk factors for developing pneumogenic bacteremia in carbapenem-resistant Acinetobacter baumannii nosocomial pneumonia in the intensive care unit: A multicenter retrospective study
by: Sheng-Huei Wang, et al.
Published: (2024-09-01)

Carbapenem Resistant Acinetobacter baumannii: Current Status of Problem in a Tertiary Care Hospital, Jaipur
by: Ekadashi Rajni, et al.
Published: (2023-06-01)

Genomic epidemiology of Acinetobacter baumannii goes global
by: Santiago Castillo-Ramírez
Published: (2023-12-01)

Effectiveness of Colistin in carbapenem resistant Acinetobacter baumannii – A systematic review
by: Feroz Ahmed, et al.
Published: (2023-09-01)

The clinical features and genomic epidemiology of carbapenem-resistant Acinetobacter baumannii infections at a tertiary hospital in Vietnam
by: Duong Thi Hong Diep, et al.
Published: (2023-06-01)

Molecular characterisation of colistin and carbapenem-resistant clinical isolates of Acinetobacter baumannii from Southeast Europe
by: Ivana Goic-Barisic, et al.
Published: (2023-06-01)

Carbapenem-resistant Acinetobacter baumannii carrier detection: a simple and efficient protocol
by: Jonathan Lellouche, et al.
Published: (2024-04-01)

Antibacterial Activity of Lavandula mairei Humbert Essential Oil Against Carbapenem-resistant Acinetobacter baumannii
by: Asma LAKTIB, et al.
Published: (2022-03-01)

Investigation of antimicrobial susceptibility patterns and frequency of bla OXA genes in carbapenem resistant Acinetobacter baumannii strains
by: Mohsen Moghadasi, et al.
Published: (2018-11-01)

Quantitative Proteomics to study Carbapenem Resistance in Acinetobacter baumannii
by: Vishvanath eTiwari, et al.
Published: (2014-09-01)

Hemorrhagic bronchitis caused by carbapenem-resistant Acinetobacter baumannii infection: A case report
by: Zifang Li, et al.
Published: (2024-01-01)

Molecular Epidemiology and Mechanisms of Carbapenem-Resistant Acinetobacter baumannii Isolates from ICU and Respiratory Department Patients of a Chinese University Hospital
by: Liu B, et al.
Published: (2021-02-01)

Molecular epidemiology of carbapenem-resistant Acinetobacter baumannii from Southern Brazil
by: Gabriel de Paula Gollino, et al.
Published: (2021-10-01)

NDM-1- and OXA-23-producing Acinetobacter baumannii in wastewater of a Nigerian hospital
by: Erkison Ewomazino Odih, et al.
Published: (2023-12-01)

Comparison of Tigecycline or Cefoperazone/Sulbactam therapy for bloodstream infection due to Carbapenem-resistant Acinetobacter baumannii
by: Tianshui Niu, et al.
Published: (2019-03-01)

Prevalence of Carbapenem Resistance in Acinetobacter baumannii Isolates from Burn and Non-Burn Patients in Tehran
by: Zahra Ghareboghy Sarmad, et al.
Published: (2015-09-01)

Prevalence of Carbapenem Resistance in Acinetobacter baumannii Isolates from Burn and Non Burn Patients in Tehran
by: Zahra Ghareboghy-Sarmad, et al.
Published: (2015-11-01)

Dynamic Gene Clusters Mediating Carbapenem-Resistant <i>Acinetobacter baumannii</i> Clinical Isolates
by: Samy Selim, et al.
Published: (2022-01-01)

The incidence and prevalence of hospital-acquired (carbapenem-resistant) Acinetobacter baumannii in Europe, Eastern Mediterranean and Africa: a systematic review and meta-analysis
by: Olaniyi Ayobami, et al.
Published: (2019-01-01)

Epidemiological characteristics of carbapenem-resistant Enterobacteriaceae and carbapenem-resistant Acinetobacter baumannii in a tertiary referral hospital in Korea
by: Sollan Kang, et al.
Published: (2022-06-01)

Antimicrobial resistance profiles and oxacillinase genes in carbapenem-resistant Acinetobacter baumannii isolated from hospitalized patients in Santa Catarina, Brazil
by: Giselle Dall Cortivo, et al.
Published: (2015-12-01)

Pharmacokinetic/pharmacodynamic (PK/PD) simulation for dosage optimization of colistin and sitafloxacin, alone and in combination, against carbapenem-, multidrug-, and colistin-resistant Acinetobacter baumannii
by: Vipavee Rodjun, et al.
Published: (2023-11-01)

Antimicrobial Susceptibility Pattern of Acinetobacter Baumannii and Rate of Carbapenem Resistance at a Tertiary Care Hospital in Karachi
by: Shomaila Malik, et al.
Published: (2017-06-01)

Pre-optimized phage therapy on secondary Acinetobacter baumannii infection in four critical COVID-19 patients
by: Nannan Wu, et al.
Published: (2021-01-01)

Characterisation of pellicle-forming ability in clinical carbapenem-resistant Acinetobacter baumannii
by: Heng Kang Ng, et al.
Published: (2023-05-01)

Risk Factors for Development and Mortality of Bloodstream Infections Caused by Carbapenem-Resistant Acinetobacter baumannii
by: Li L, et al.
Published: (2024-12-01)

Carrimycin, as One of the Drugs in Combination Therapy, for the Treatment of Carbapenem-Resistant Acinetobacter Baumannii Infection
by: Du N, et al.
Published: (2024-08-01)

Transcriptomic investigations of polymyxins and colistin/sulbactam combination against carbapenem-resistant Acinetobacter baumannii
by: Xingchen Bian, et al.
Published: (2024-12-01)